HOWL Strangle Strategy
HOWL (Werewolf Therapeutics, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
Werewolf Therapeutics, Inc., a biopharmaceutical company, develops therapeutics engineered to stimulate the body's immune system for the treatment of cancer. The company, through its proprietary PREDATOR platform, designs conditionally activated molecules that stimulate adaptive and innate immunity for addressing the limitations of conventional proinflammatory immune therapies. Its lead product candidates are WTX-124, a conditionally activated Interleukin-2 INDUKINE molecule for the treatment of advanced solid tumors; and WTX-330, a conditionally activated Interleukin-12 INDUKINE molecule for the treatment of relapsed or refractory advanced or metastatic solid tumors or lymphoma. The company is also developing WTX-613, a conditionally activated interferon alpha INDUKINE molecule for the treatment of solid tumors and hematologic malignancies. Werewolf Therapeutics, Inc. was incorporated in 2017 and is headquartered in Cambridge, Massachusetts.
HOWL (Werewolf Therapeutics, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $28.4M, a beta of 0.41 versus the broader market, a 52-week range of 0.502-2.38, average daily share volume of 425K, a public-listing history dating back to 2021, approximately 46 full-time employees. These structural characteristics shape how HOWL stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.41 indicates HOWL has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure.
What is a strangle on HOWL?
A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money.
Current HOWL snapshot
As of May 15, 2026, spot at $0.52, ATM IV 21.10%, IV rank 0.89%, expected move 6.05%. The strangle on HOWL below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.
Why this strangle structure on HOWL specifically: HOWL IV at 21.10% is on the cheap side of its 1-year range, which favors premium-buying structures like a HOWL strangle, with a market-implied 1-standard-deviation move of approximately 6.05% (roughly $0.03 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated HOWL expiries trade a higher absolute premium for lower per-day decay. Position sizing on HOWL should anchor to the underlying notional of $0.52 per share and to the trader's directional view on HOWL stock.
HOWL strangle setup
The HOWL strangle below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With HOWL near $0.52, the first option leg uses a $0.55 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed HOWL chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 HOWL shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $0.55 | N/A |
| Buy 1 | Put | $0.49 | N/A |
HOWL strangle risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit.
HOWL strangle payoff curve
Modeled P&L at expiration across a range of underlying prices for the strangle on HOWL. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use strangle on HOWL
Strangles on HOWL are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the HOWL chain.
HOWL thesis for this strangle
The market-implied 1-standard-deviation range for HOWL extends from approximately $0.49 on the downside to $0.55 on the upside. A HOWL long strangle is the OTM cousin of the straddle: lower up-front cost but the underlying has to travel further past either OTM strike before the position turns profitable at expiration. Current HOWL IV rank near 0.89% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on HOWL at 21.10%. As a Healthcare name, HOWL options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to HOWL-specific events.
HOWL strangle positions are structurally neutral / high-volatility (long premium, OTM); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. HOWL positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move HOWL alongside the broader basket even when HOWL-specific fundamentals are unchanged. Always rebuild the position from current HOWL chain quotes before placing a trade.
Frequently asked questions
- What is a strangle on HOWL?
- A strangle on HOWL is the strangle strategy applied to HOWL (stock). The strategy is structurally neutral / high-volatility (long premium, OTM): A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money. With HOWL stock trading near $0.52, the strikes shown on this page are snapped to the nearest listed HOWL chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are HOWL strangle max profit and max loss calculated?
- Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit. For the HOWL strangle priced from the end-of-day chain at a 30-day expiry (ATM IV 21.10%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a HOWL strangle?
- The breakeven for the HOWL strangle priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current HOWL market-implied 1-standard-deviation expected move is approximately 6.05%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a strangle on HOWL?
- Strangles on HOWL are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the HOWL chain.
- How does current HOWL implied volatility affect this strangle?
- HOWL ATM IV is at 21.10% with IV rank near 0.89%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.